Akrevia Therapeutics has raised a $30 million series A round led by F-Prime Capital Partners and Atlas Venture. The financing sets up a team led by ex-Ariad and Intellia executives to advance a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback